FDAFDA · Food and drugs·Recall number D-0720-2021
Zyprexa Intramuscular, Olanzapine for Injection, 10 MG per Single Use Vial, Rx only, Marketed by: Lilly USA, LLC, Indianapolis, IN 46285, NDC# 0002-7597-01
Published August 18, 2021 · Recall initiated: June 29, 2021
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
cGMP deviations: Atypical appearance, decrease in size and change in color of the lyophilized cake of drug product.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Manufacturer
- Eli Lilly & Company
- Distributor
- OH, MS, IN
- Lot
- Lot # 197
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.